About Mercy Cell
Born from Academia Sinica research, we develop revolutionary cell therapies to restore sight and transform the lives of millions living with blindness.
Mission & Vision
Our Mission: Restoring sight, improving lives. We develop next-generation cell therapies to give hope back to millions living with retinal diseases and blindness.
Our Vision: A world where blindness from retinal degeneration is no longer irreversible. We aim not only to preserve vision but to restore it — returning dignity, independence, and opportunity to patients and families worldwide.
Through our revolutionary CiRPCs technology, we're transforming what was once impossible into achievable therapeutic reality.
Restoring Vision
Our Core Values
Three fundamental principles guide our research, development, and commitment to transforming lives.
Innovation
We push the boundaries of scientific possibility, developing breakthrough CiRPCs technology that transforms retinal progenitor cell generation from months to just 5 days.
Integrity
Every aspect of our research and business practices upholds the highest ethical standards, ensuring patient safety and scientific rigor in our pursuit of vision restoration.
Impact
We measure success by the lives transformed. Our focus extends beyond scientific achievement to delivering meaningful, accessible treatments that restore dignity and independence.
Academia Sinica
Taiwan's Premier Research Institution
Origin Story
Mercy Cell was born from groundbreaking research at Academia Sinica, Taiwan's premier academic research institution. Our founders recognized that the world's most promising retinal regeneration research needed a focused, mission-driven company to translate laboratory breakthroughs into life-changing treatments.
What began as academic curiosity about cellular reprogramming has evolved into a revolutionary platform technology that can generate functional retinal progenitor cells with unprecedented speed and efficiency.
Today, we bridge the gap between world-class research and real-world impact, maintaining our scientific rigor while accelerating toward clinical applications that will restore sight to millions.
Our Journey
Recognition and major milestones marking our progress toward transforming vision restoration.
National Innovation Award
Recognized for breakthrough CiRPCs technology and its potential to revolutionize treatment for retinal degenerative diseases. This prestigious award validates our scientific approach and clinical promise.
Future Technology Award
Honored for developing next-generation cellular reprogramming technology that accelerates retinal cell generation from months to days, opening new possibilities for scalable vision restoration therapies.
Join Our Mission
Whether you're a researcher, clinician, investor, or patient, there are many ways to be part of our mission to advance cellular therapies.